clinical trial

(redirected from Phase 3 clinical trial)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for clinical trial

a rigorously controlled test of a new drug or a new invasive medical device on human subjects

References in periodicals archive ?
Clevudine is a potent HBV antiviral currently in Phase 3 clinical trials in Korea and has been the subject of earlier stage clinical trials under an Investigational New Drug application filed with the US FDA.
The companies are conducting a 600 patient Phase 3 clinical trial of the Intercept Platelet System in the United States.
Modification of the secondary endpoints in the current Phase 3 clinical trial to include molecular disease status, potentially accelerating the difference in remission between BiovaxID and control in the clinical study
NASDAQ:SOMX) today announced positive results from the company's Phase 3 clinical trial evaluating SILENOR[TM] (doxepin HCl) in elderly patients with chronic primary insomnia.
Somaxon's lead product candidate, SILENOR([TM]) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia.
The decision to discontinue the Phase 3 clinical trial of Canvaxin(TM) in patients with Stage III melanoma was based upon the recommendation of the independent Data and Safety Monitoring Board (DSMB).
Nasdaq: PGNX) today announced positive top-line results from a pivotal phase 3 clinical trial of its investigational drug, methylnaltrexone (MNTX) for the treatment of opioid-induced constipation in patients with advanced medical illness (AMI).
Hale will also provide an update on the Company's two Phase 3 clinical trials for its lead product candidate, Canvaxin(TM), and will discuss recent enhancements to the Company's product pipeline.
CancerVax Corporation (NASDAQ:CNVX) announced today that it has completed the planned enrollment of 1,118 patients into its Phase 3 clinical trial of Canvaxin(TM) for the treatment of patients with Stage III melanoma.
and Roche Holdings AG, announced positive results from a randomized, Phase 3 clinical trial in late-stage NSCLC for their EGFR tyrosine kinase inhibitor, Tarceva(TM) (erlotinib HCl).
CancerVax Corporation (NASDAQ: CNVX) announced today that an independent Data and Safety Monitoring Board (DSMB) completed its planned, second, interim analysis of the Company's randomized, double-blind, international Phase 3 clinical trial of its investigational immunotherapy, Canvaxin(TM), for the treatment of patients with Stage III melanoma.
Even if this Phase 2 clinical trial is successful, Inspire cannot, at this point, predict the timing or success of future trials, including additional Phase 2 or Phase 3 clinical trials, for INS50589.
NASDAQ: ACUS) today announced that it has completed enrollment in its "32" trial, one of two Phase 3 clinical trials for the Company's lead product candidate, AI-700.
The Phase 3 clinical trials for retigabine will consist of two global studies -- the first in the United States, Mexico and South America with up to 45 sites, and the second in other major markets around the world with up to 60 sites.